MONTREAL, CANADA, Oct. 10, 2013 -- GLV Inc. (Group GLV) announced that a wastewater treatment plant in the city of Canton, Ohio will be upgraded by its business unit Ovivo, delivering the largest membrane bioreactor (MBR) in the United States.
The projected start date for commissioning the new plant is planned to be 2015 with a completion due in 2017. The project total costs are about $90 million, of which $28 million are for the Ovivo's MBR system.
"Since the 1990s, or even earlier, MBR solutions have been recognized as best available treatment technology from an environmental standpoint. However, cost and energy were higher than conventional treatment alternatives," said Marc Barbeau, president of Ovivo and executive vice president of GLV Inc., in a conference held by the city of Canton on Thursday, Oct. 10. "Now, as the result of numerous system and equipment innovations, this project and many others are signaling that MBR is the technology of today and the technology of the future."
About GLV Group (GLV Inc.)
GLV Group is comprised of international businesses primarily active in the sectors of water treatment (Ovivo) and pulp and paper (GL&V Pulp and Paper) that offers comprehensive technological solutions as well as services and equipments tailored to the needs of its customers. GLV Group's business units operate in more than 25 countries and employ approximately 2,100 employees. GLV Inc. is a public company whose shares are traded on the Toronto Stock Exchange under the symbols GLV.A and GLV.B. www.glv.com.